Apellis Pharmaceuticals Inc (APLS)

41.30 -0.70 (-1.67%) USD  |  NASDAQ  |  May 17, 16:00
41.25 -0.05 (-0.12%) After-Hours: 06:26
More

Apellis Pharmaceuticals Current Deferred Revenue (Quarterly)

Current Deferred Revenue (Quarterly) Chart

View Current Deferred Revenue (Quarterly) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Current Deferred Revenue (Quarterly) Data

View and export this data back to 2024. Upgrade now.
Date Value
March 31, 2024 --

Current Deferred Revenue (Quarterly) Range, Past 5 Years

Upgrade
Minimum
Mar 2024
Upgrade
Maximum
Mar 2024
Upgrade
Average
Upgrade
Median
Mar 2024

Current Deferred Revenue (Quarterly) Benchmarks

Inspire Medical Systems Inc --
Sarepta Therapeutics Inc Upgrade
Blueprint Medicines Corp Upgrade
Alnylam Pharmaceuticals Inc Upgrade
Cytokinetics Inc --